Podcasts about cme

Become the Medetomi-Dean of AdmissionsStep up your hospital addiction medicine game by learning to troubleshoot methadone dose confirmations/missed doses and understanding how medetomidine's emergency in the drug supply is impacting patients and withdrawal management. We're joined by Dr Maggie Lowenstein (University of Pennsylvania)Claim CME for this episode at curbsiders.vcuhealth.org!By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME!Credits Writer, Producer, and Show Notes: Shawn Cohen MD Infographic and Cover Art: Zoya Surani  Hosts: Carolyn Chan, MD. MHS and Shawn Cohen MD Reviewer: Payel Jhoom Roy MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest:  Maggie Lowenstein MD MPhil MSHP Sponsor: BabbelGo to Babbel.com/CURB for up to 60% off.Sponsor: FIGSCurbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.Sponsor: FreedSetup takes 30 minutes and pricing starts at $149 a month. Try it free for 7 days at getfreed.ai/front-desk.

Update Series (2026): Kidney Stones and the Infected Patient Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Mantu Gupta, MD Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. For more information or to subscribe to the AUA Update Series, please visit CME.auanet.org

Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== In this solo masterclass, John walks through the five steps he took to go from a family medicine physician to a hospital chief medical officer, and how to do so more intentionally than he did. It took him about 20 years. With the right approach, he believes it can be done in far less time. The five steps are straightforward:  Start volunteering in non-clinical hospital roles and say yes to opportunities, Find one or more mentors, Take on part-time medical director or physician advisor work while still practicing, Pursue formal business and management education, and Ask for the job.  John works through each using his own career as the example, including how chairing a hospital CME committee eventually led to a national accreditation role at the ACCME.  You'll find links mentioned in the episode at nonclinicalphysicians.com/path-to-hospital-executive/.

Interview conducted with Prof Bernd Kasper on March 5, 2026, by Dr Neil Love, including the following topics: Current management of desmoid tumors: A review from the Desmoid Tumor Working Group (0:00) Long-term nirogacestat treatment in adult patients with desmoid tumors: Updated efficacy and safety from the Phase III DeFi trial (8:26) Phase IV trial of nirogacestat in adult premenopausal women with desmoid tumors (17:35) CME information and select publications here.

Send us Fan MailWhy do some medical groups thrive while others constantly struggle — even in the same market?Have you ever looked at two practices in the same city, with similar physicians, similar patient populations, and similar payer contracts… and wondered why one group seems calm, strategic, financially healthy, and growing — while the other feels stressed, chaotic, reactive, and constantly fighting fires?That difference is rarely luck. High-performing medical groups think differently. They make decisions differently. They build systems differently. They lead differently. They invest differently. And perhaps most importantly, they understand that success in healthcare today requires far more than simply being clinically excellent.Because let's be honest — almost every physician group is working hard. That's not the differentiator anymore. The differentiator is operational intelligence. The differentiator is leadership. The differentiator is culture. The differentiator is the ability to think strategically instead of reactively.And today, we're going to talk about what high-performing medical groups actually do differently. Not from a theoretical textbook perspective. From the real-world trenches of healthcare operations. Because thriving organizations don't happen accidentally. They are built intentionally.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000 Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/    

Près de 250 morts et plus de 1100 cas recensés : le virus Ebola est toujours actif dans l'est de la RDC. Il n'y a pour l'instant ni vaccin ni traitement miracle mais parfois la maladie recule… Ca été le cas récemment à Bunia. « Au Centre médical évangélique, relate Le Journal de Kinshasa, l'air était plus léger dimanche. Plus chaud. Presque électrique. Devant une petite assemblée de journalistes venus en silence, quatre hommes et une femme s'avancent, sourire aux lèvres, regard fier. Ils ne sont plus des malades. Ils sont des survivants. Quatre nouveaux patients soignés pour Ebola viennent d'être déclarés guéris. Un cinquième l'avait été un peu plus tôt. En tout, se félicite le site congolais, cinq vies arrachées à la maladie, là où l'ombre du virus plane encore. Tous partagent un même destin : ils sont infirmiers. Et tous ont été contaminés… en sauvant des vies. Le docteur Calvin Ambitapio, directeur médical du CME, ne cache pas son émotion. Devant les micros, il livre un témoignage rare, presque inattendu : "nous sommes très contents de voir qu'une maladie qui n'a ni traitement propre, ni vaccin pour le moment, peut être vaincue par un traitement symptomatique". Alors, s'interroge Le Journal de Kinshasa, quel est ce protocole qui redonne espoir ? Une approche simple, mais rigoureuse : prise en charge du paludisme, antibiothérapie adaptée, surveillance quotidienne, prélèvements répétés. Pas de molécule miracle. Du soin. De l'attention. De l'acharnement thérapeutique. Résultat : après plusieurs jours d'observation, les tests sont tombés. Un par un. Négatifs ». Convaincre les populations Pour Afrik.com, « ces guérisons dépassent le seul cadre médical. La riposte contre Ebola se joue aussi dans la capacité à convaincre les populations que le soin peut sauver. Ces infirmiers rétablis à Bunia sont désormais la preuve vivante qu'un diagnostic précoce et une prise en charge adaptée peuvent augmenter considérablement les chances de survie. Leur guérison contredit l'idée, encore présente dans certaines localités touchées, selon laquelle l'entrée dans un centre de traitement équivaut à une condamnation. Dans cette bataille, la confiance devient donc un outil à part entière, relève encore Afrik.com. Sans adhésion des habitants, les protocoles médicaux les plus solides peuvent se heurter à la peur, aux soupçons et aux refus de prise en charge ». Pour sa part, le gouvernement congolais « affiche un optimisme prudent », relève La Tempête des Tropiques. « Le ministre de la Santé, Samuel Roger Kamba Mulamba, a estimé que la maladie pourrait être maîtrisée dans un délai de quatre à six mois grâce au renforcement de la riposte, à l'engagement communautaire et au soutien des partenaires internationaux ». La baisse des aides : une faute morale… Reste que « l'est de la RDC n'a pas seulement besoin d'interventions d'urgence, mais d'un engagement durable » : c'est ce qu'affirme dans une tribune publiée par Le Monde Afrique le médecin épidémiologiste humanitaire Didier Cannet. « Dans de nombreuses zones de l'Est congolais, l'État ne parvient plus à assurer ses fonctions essentielles, dit-il : sécurité, santé, éducation, infrastructures et protection des civils. Les systèmes de santé survivent grâce aux ONG internationales et aux financements extérieurs. Depuis plusieurs mois, la réduction de l'aide publique au développement et la baisse de certains financements américains, notamment par le biais de l'Usaid, l'Agence américaine pour le développement international, fragilisent encore davantage un système déjà au bord de la rupture. Cette situation constitue non seulement une faute morale, s'exclame le docteur Didier Cannet, mais aussi une erreur stratégique majeure, car les épidémies qui émergent dans l'est de la RDC ne resteront pas confinées indéfiniment dans les camps de déplacés de Goma ou dans les territoires isolés de l'Ituri ». Mauvais calcul… En effet, renchérit Jeune Afrique, en démantelant l'Usaid, l'administration Trump a fait un « mauvais calcul. (…) La prochaine pandémie coûtera probablement beaucoup plus cher que les milliards économisés aujourd'hui sur l'aide internationale. L'épidémie d'Ebola en RDC en donne déjà un aperçu ». Alors, certes, poursuit le site panafricain, « l'Afrique ne peut éternellement dépendre de Washington, de Bruxelles ou de Genève pour financer sa sécurité sanitaire. Elle doit encore bâtir des systèmes de santé plus solides, mieux financés et capables de répondre rapidement aux éventuelles menaces. Or, on en est loin. Mais prétendre que cette transition peut se faire alors que les financements internationaux ont été coupés net, c'est comme démonter des digues en arguant que la tempête n'a pas encore éclaté ».

Malignant Bowel Obstruction, VTE and Goals of CareMaster malignant bowel obstruction, cancer-associated thrombosis, and goals-of-care conversations in hospitalized patients with advanced cancer. Learn practical approaches to symptom management, anticoagulation decisions, and navigating high-stakes discussions around prognosis and hospice care. We're joined by  Dr. Jensa Morris, @JensaMorrisMD (Yale School of Medicine).Claim free CME for this episode at curbsiders.vcuhealth.org!Show Segments Intro Picks of the Week Case 1: Malignant small bowel obstruction: definitions, initial management, medications, NG tubes, nutrition, and procedural options Case 2: Cancer-associated VTE: choice of anticoagulant, treatment duration, unusual thromboses, and anticoagulation with brain metastases  Case 3: Goals of care: prognosis, performance status, palliative care, hospice and end-of-life planningTake Home Points Outro  Credits Writer, producer, and show notes: Reaford Blackburn, Jr., MD Infographic, Cover Art: Caroline Coleman, MD Hosts: Monee Amin, MD and Meredith Trubitt, MD    Reviewer: Rahul Ganatra, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Jensa Morris, MD Sponsor: Continuing Education CompanyVisit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.  Sponsor: LocumstoryLocumstory.com is literally just a free, unbiased resource dedicated to educating physicians about locums.Sponsor: Mint MobileTo get your new wireless plan for just 15 bucks a month, go to mintmobile.com/CURB. 

In this episode, Drs. Jason Silverman and Amber Hildreth talk to Dr. Valeria Cohran about the advances in intestinal rehabilitation care for infants and children with short bowel syndrome including changes nutrition management, line care and use of GLP-2 analogues that have led to decreases in intestinal failure associated liver disease and transplantation. Learning objectivesTo understand the composition and impact of multidisciplinary intestinal rehabilitation teams.To review the historical presentation of intestinal failure-associated liver disease (IFALD) and changes in practice that have reduced its prevalence and severity.To review GLP-2 analogues and their impact on outcomes and quality of life for children with short bowel syndrome. LinksPapers mentioned:PIFCON data paper on IFALDCholestasis and infection in long-term PNManagement of CVL in SBS Position PaperIntestinal Rehabilitation Teams Practice GuidelinePrevious episodes mentioned:Sue Protheroe - Enteral Nutrition in Intestinal FailureDanielle Wendel - Central Line Management in Intestinal Failure (Special JPGN Episode)Ruben Quiros-Tejeira - Multivisceral TransplantationPaul Wales - Surgical Management in Short Bowel SyndromeValeria Cohran & Conrad Cole - Racism in MedicineSend us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

In this episode, the crew discusses Bitcoin's current consolidation and MicroStrategy's recent wallet movements, while debating whether we're in a prolonged bear phase or setting up for the next leg up. Key highlights include the NYSE CEO calling Hyperliquid bigger than NASDAQ, CFTC approvals for the first regulated Bitcoin perps on Kalshi and Coinbase's Deribit access, CME launching 24/7 crypto futures, and Paxos winning SEC approval for on-chain U.S. stock settlement. The conversation also covers AI's impact on markets, liquidity rotation into big IPOs like SpaceX, altcoin consolidation, and the long-term fusion of crypto with traditional finance. Bullish developments vs. near-term caution — a must-listen Friday roundup. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bitcoin just cratered to a six week low below $73,000 as fresh U.S. airstrikes on Iran reignited Strait of Hormuz war fears, triggering $897 million in long liquidations and the second largest daily IBIT outflow on record at $528 million. The pain is everywhere right now. Fund manager Michael Kramer is warning a $150 billion Treasury liquidity drain over the next week could send BTC much lower, while CME finally killed the famous weekend gap by launching 24/7 futures trading. Meanwhile, Iran is calling negotiations a strategic deadlock, the CFTC made a stunning admission that the Gemini case never should have been filed, the FBI just seized a record $8 billion in Bitcoin from a Cambodian scam compound, and Paxos became the first blockchain native firm approved by the SEC to clear and settle U.S. securities on chain. Plus a single enterprise client racked up a $500 million Claude bill in 30 days with no usage limits. We are breaking down whether Bitcoin defends $72K or rolls over to new lows, what the Hormuz escalation means for risk assets, and why this could be the most consequential 24 hours of the entire cycle. Learn more about your ad choices. Visit megaphone.fm/adchoices

BEEF I've been saying for weeks to stay ahead of your needs, and I'm going to reiterate, stay ahead of your needs, as demand does seem to be ticking up a bit. Weekly harvest is not moving up to help meet that demand. Last week's harvest was 528K head, down from the prior week's 535K head. While middle meats are struggling to move higher, ground beef is on the march higher every day. Retail ground beef is now averaging over $7/# for the first time…ever. I don't see this backing off any time soon. Increases in chucks and rounds are very modest but they are moving higher again. Thin meats, briskets, flanks, sirloin flap, are showing some weakness, we could see a correction on this over the next couple of weeks, but it will be pretty minor. Staying with the theme, keep ahead of your needs. POULTRY Boneless Skinless breasts decline again for next week. Getting to be a pretty big spread between breast meat and tenderloins, tenderloins holding pretty steady. Wings holding steady next week too. Production continues over last year running almost 3% up from over last year. Breast meat is turning into a great value as the price declines. On the Avian flu beat, a really good week, two new cases totaling 11,600 ducks.  GRAINS Corn declined this week, closing today at $4.62 down from last week's $4.75 close. Wheat was showing signs of a bit of a run, but that is about done, we could see wheat decline over the next couple weeks. Soy was actually showing some weakness, until Tuesday this week, soy is now on the move higher. This could be short lived, but right now, soy oil is moving up.  PORK Pork bellies bottomed out last week at $104. Today's close $112. Still a great value for this time of year, I'm buying bacon. Summer is typically a high demand time for butts and ribs, and both are moving up steadily. Loins continue to be a great protein value. DAIRY CME Last week the CME looked like it was going to move overall lower. This week thru Thursdays close, butter is up 3 while block and barrel both declined another 5 cents. We'll keep watching but I don't see much to push higher in the short term. Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPN865. CME credit will be available until May 18, 2027.Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to ResolutionThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

Lavon Medlock has spent over two decades enhancing leaders' skills in problem-solving and coaching. Skilled in a variety of continuous improvement methods, she has trained leaders in creating effective daily management systems, deployed an integrated facility design approach to new construction projects like a 90,000-square-foot patient tower, and enhanced operations across different sectors.With a primary focus on the healthcare industry, Lavon has worked with clinical leaders to combine the Institute of Healthcare Improvement's teachings on quality with A3 thinking and key project management principles. She's a practitioner, teacher, and coach in the field of A3 thinking and holds certifications in both Project Management (PMI-PMP) and Six Sigma Green Belt.In addition to instructing and coaching for the Lean Enterprise Institute, she teaches graduate coursework at The Ohio State University. Her educational background includes a Bachelor of Science in Public Health from the University of North Carolina at Chapel Hill and a Master of Science in Healthcare Administration from Oregon Health & Science University.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

With an abundance of therapeutic options for managing diabetic macular edema (DME), what patient characteristics inform your treatment decisions? Does the number of loading doses influence long-term macular fluid outcomes? How are you managing insurance-mandated step-therapy in your patients? In today's episode, host Dr. Jay Sridhar invites Drs. Durga Borkar and Carl Danzig to share how they've integrated new anti-VEGF therapies into clinical practice. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Proceedings from a webinar on April 16, 2026, moderated by Dr Neil Love, including the following topics: Introduction: Research To Practice Paper of the Year! (0:00) Checkpoint Inhibitors for Localized Microsatellite Instability-High Tumors (11:12) Circulating Tumor DNA Assays (21:58) Checkpoint Inhibitors for Metastatic Disease (38:32) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 2: Optimizing the Care of Patients with Nonmetastatic Colorectal Cancer (CRC) — Arvind Dasari, MD, MS CME information and select publications

In this episode, Lillian Erdahl, MD, FACS, is joined by Pringl Miller, MD, FACS, from Physican Just Equity, and Christine Heisler, MD, FACS, from the Mayo Clinic Health System. They discuss Drs Miller and Heisler's recent article, “Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of American College of Surgeons Members,” in which the authors found that the most frequent perpetrator roles were surgeon colleagues and supervisors. A total of 57.4% of surgeons took action, with informal reporting to a colleague and/or directly confronting the perpetrator being most common actions taken. Surgeons who took action were less likely to choose a career in surgery again.   Disclosure Information: Drs Erdahl, Miller, and Heisler have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Heisler, Christine A MD, MS, FACS; Godecker, Amy L PhD, MS; Verran, Deborah MbChB, MHSM; Sinha, Michael S MD, JD, MPH; Byam, Jerome MD; Miller, Pringl MD, FACS. Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of the American College of Surgeons Members. Journal of the American College of Surgeons 242(2):p 390-400, February 2026. | DOI: 10.1097/XCS.0000000000001648   Related work: Primary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Workplace microaggressions: results of a survey of the American College of Surgeons members. Am J Obstet Gynecol. 2024 Aug;231(2):265.e1-265.e8.   Secondary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Impact of Workplace Microaggressions on Surgeon Career Status and Trajectory: A Cross-Sectional Survey Study.  Accepted to the Annals of Surgery Open on April 30, 2026.     The secondary study was also presented at ACS Clinical Congress 2024: Heisler CA, Godecker A, Verran D, Sinha MS, Byam J, Miller P. Workplace Microaggressions and the Impact on a Surgeon's Career Trajectory: Results of a Survey of the American College of Surgeons Members. J Am Coll Surg. October 2024;239(5):S138-139.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Interview conducted on March 11, 2026, by Dr Neil Love, including the following topics: Circulating tumor DNA (ctDNA)-guided adjuvant therapy with atezolizumab for muscle-invasive bladder cancer (MIBC) (0:00) Use of ctDNA in guiding systemic treatment selection for patients with urothelial bladder cancer (10:03) ctDNA analyses with perioperative durvalumab for MIBC in the Phase III NIAGARA study (16:51) New research advances in the monitoring and management of urothelial bladder cancer (22:21) CME information and select publications  

In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the May 2026 Emergency Medicine Practice article, Emergency Department Evaluation and Management of Serious and High-Risk Infections in the Febrile Returning Traveler.0:16 — Podcast Introduction1:08 — Episode Introduction7:30 — Malaria13:55 — Dengue17:33 — Enteric Fever (Typhoid/Paratyphoid)20:53 — Leptospirosis22:43 — Clinical Presentations26:33 — Diagnostic Testing33:17 — Treatment38:59 — Special Populations & Risk Pitfalls43:05 — Closing Pearls & OutroSubscribers, take the CME test here. Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast CME Available: https://cme.auanet.org/URL/FOCUS262ONL LEARNING OBJECTIVES: After participating in this CME activity, participants will be able to: 1. Critically appraise recent developments in imaging biomarkers and molecular diagnostics (e.g., genomic risk scores, liquid biopsy) and discuss how they complement MRI and PSMA PET in prostate cancer care. 2. Determine the optimal clinical scenarios (diagnostic, staging, recurrence, surveillance) in which PSMA PET/CT or PET/MRI adds value beyond conventional imaging. 3. Recognize potential pitfalls in PSMA PET interpretation — including false positives, false negatives, non–PSMA-expressing disease, and technical artifacts — and implement strategies to mitigate them. 4. Synthesize biomarker, MRI, and PSMA PET findings into a personalized management plan, including guiding biopsy, focal therapy, salvage therapy, or systemic treatments. 5. Select appropriate patients with radiorecurrent or organ-confined prostate cancer for advanced imaging and guide re-treatment decisions (e.g., salvage therapy, targeted radiotherapy). ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Blue Earth Diagnostics, Inc. Lantheus Medical Imaging

What roles do data and storytelling play in DEI work? How we can share our perspectives and learn from each other while remaining civil?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Celeste Warren, a DEI consultant and published author. They take a closer look into why it's more important now than ever to continue doing DEI work and the impacts of grounding in the fundamental values of an organization.Celeste Warren is a visionary leader who had an impressive 28-year tenure at a global Fortune 100 company, where she rose to the esteemed position of Vice President and Chief Diversity & Inclusion Officer. During her decade-long leadership of the Global Diversity and Inclusion Center of Excellence, Celeste implemented groundbreaking initiatives that fostered a culture of inclusivity and equity, setting new standards in the industry.Celeste is a published author and her articles on diversity, equity and inclusion have been featured in numerous national and global publications and she has had the opportunity to speak at various events across the world. She has recently published her second book entitled “The Truth About Equity, What It Really Is, What It Isn't and Why Everyone Wins When We Get It Right.”LINKSwww.crwdiversity.com**You can learn more about Dr. Wener's coaching, EFT/Tapping and meditation offerings at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareFollow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher explore three questions that reach across medicine, leadership and life itself: What legacy do physicians leave behind? How does mindset shape health and longevity? And can doctors still find fulfillment as medical practice shifts from independence to employment? The conversation begins with Tim Cook's legacy at Apple, using his tenure as CEO to ask a larger question about values, mission and compromise. Pearl and Fisher examine whether legacy is something others assign after a career ends or something professionals create daily through their choices, actions and alignment with their deepest values. For physicians, the question becomes especially personal when financial, organizational or career decisions collide with the promise to put patients first. Midway through, the discussion turns to longevity and the science of mindset. Drawing on research from Yale and Fisher's work in Just One Heart, the two physicians explore how beliefs about aging can influence physical function, cognitive health, inflammation and long-term well-being. Fisher explains why optimism is not merely a pleasant attitude but a physiologic force that can shape stress hormones, inflammatory pathways and the daily behaviors that determine health. Finally, Pearl and Fisher examine one of the biggest structural shifts in modern medicine: the movement from physician-owned practices to employment by hospitals, health systems and insurers. Fisher notes that independent doctors may report lower burnout, but autonomy is no longer guaranteed when administrative burdens, call schedules and financial pressures consume the practice of medicine. Employment offers support and stability, but often at the cost of control. By the end, the episode connects all three themes: legacy, health and professional fulfillment are rooted in purpose. Whether through family, patient care, mission trips, mentoring or the daily work of medicine, Pearl and Fisher suggest that doctors may live longer, healthier and more meaningful lives when they preserve the mission that brought them to medicine in the first place. For listeners who connected with Fisher's reflections on burnout, autonomy and the search for renewed purpose in medicine, his upcoming ASPIRE physician retreat offers a deeper opportunity for reflection and recovery. Co-facilitated with Dr. Robyn Tiger, ASPIRE is a CME-accredited retreat designed exclusively for healthcare professionals, taking place June 12-14 at the Art of Living Retreat Center in Boone, North Carolina. Use code ASPIRE15 for 15% off registration. For more unfiltered conversation, listen to the full episode and explore these related resources: ‘Just One Heart' (Jonathan Fisher's newest book) ‘ChatGPT, MD' (Robert Pearl's newest book) Monthly Musings on American Healthcare (Robert Pearl's newsletter) * * * Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post FHC #216: An unfiltered look at what legacy means in medicine appeared first on Fixing Healthcare.

The ongoing outbreak of hantavirus infections that originated with passengers on the Dutch cruise ship MV Hondius in April has generated concerns across the globe. This very rare occurrence has led to a number of deaths, required quarantining of passengers and prompted emergency responses from public health authorities in multiple countries.  On this episode of Raise the Line from Elsevier, we're tapping the expertise of a leading authority on the subject, Dr. Jamie Childs of Yale University, to provide you with a scientific understanding of hantaviruses and what level of threat is posed by this situation. In short, Dr. Childs believes this is not the start of a pandemic. “The Andes variant involved here is one of the most dangerous hantaviruses, but it is totally controllable with contact tracing.” This timely conversation with host Lindsey Smith is informed by Dr. Childs' decades of hantavirus research as well as learnings from his role leading the CDC's environmental investigation during the landmark 1993 hantavirus outbreak in the Four Corners region of the American Southwest. And be sure to stay tuned to hear his concerns about the factors complicating containment of the current Ebola outbreak in East Africa. Note: this conversation was recorded on May 19th, 2026. Mentioned in this episode: Yale School of Public Health Yale Institute for Global Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Send us Fan MailWhat if your organization's biggest revenue problem has nothing to do with payer contracts?Think about that for a moment.Because in healthcare, we spend enormous amounts of time obsessing over payer negotiations, denials, collections, reimbursement schedules, staffing ratios, labor costs, and operational efficiency. Entire leadership meetings are devoted to squeezing another one or two percent out of contracts.But what if the revenue problem starts long before the claim is ever submitted? What if the biggest leak in your organization is happening quietly, invisibly, every single day inside the clinic? Today we're uncovering the million-dollar problem nobody is talking about: physician undercoding.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000  Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/    

Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists holds and procedures, the newest drug in pancreatic cancer, and discontinuing thyroid supplementation. Fill your brain hole with a delicious stack of hotcakes! Featuring Drs. Nora Taranto (@norataranto), Laura Glick (@lauraglick) and Matt Watto (@doctorwatto).Claim free CME for this episode at curbsiders.vcuhealth.org!Episodes | Subscribe | Spotify | Swag! |Mailing List | Contact | CME!Credits Written and Hosted by: Nora Taranto MD MSCE, Laura Glick MD,  Matthew Watto MD, FACP Cover Art:  Nora Taranto MD MSCE Reviewers: Emi Okamoto MD  Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro and pun   Lipid Management Guidelines Overview  Emerging Treatments in Oncology  Press Release on a new KRAS Inhibitor for Pancreatic Cancer  Perioperative Considerations for GLP-1 Use  Deprescribing Levothyroxine in Older Adults Sponsor: Panacea FinancialIf you're about to make the leap into  residency and feeling the financial pressure of that transition, visit  PanaceaFinancial.com/curbsiders today. Sponsor: UpToDatefor a limited time, get 10% off UpToDate packages with code CURB10. Visit store.uptodate.com to save on your annual or longer personal UpToDate subscription today. 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Proceedings from a webinar on March 11, 2026, moderated by Dr Neil Love, including the following topics: Introduction: I think I missed that day in med school (BTK biology) (0:00) First-Line Treatment (11:40) Relapsed/Refractory Disease (46:35) CME information and select publications

Rebecca from Jito Labs joins Haseeb, Tom, and Tarun for a regulation deep-dive covering the CLARITY Act's stablecoin yield compromise and presidential ethics sticking points, CME and ICE's lobbying war against Hyperliquid's RWA perps, the prediction market legal battle heading to the Supreme Court, and whether the SEC's tokenized securities innovation exemption will actually matter. Welcome to The Chopping Block – where crypto insiders Haseeb Qureshi, Tom Schmidt, Tarun Chitra, and Robert Leshner chop it up about the latest in crypto. This week, joining us is Rebecca Rettig, Chief Legal Officer at Jito Labs, who's here to help the crew make sense of the absolute regulatory tornado tearing through the industry. First up: the CLARITY Act. It just got out of Senate Banking Committee, but the road to passage is anything but smooth. The stablecoin yield fight with banks ended in a "do stuff yield" compromise, but presidential ethics provisions remain the last polarizing hurdle. Rebecca breaks down what actually changes for token founders if it passes — spoiler: not much immediately, since rulemaking alone could take years. Then: CME and ICE have declared war on Hyperliquid, lobbying the Hill to force CFTC registration on the decentralized perps giant. The crew debates who actually wins US regulated perps, whether Hyperliquid's pre-IPO markets represent a genuine threat to investment banking, and Rebecca introduces "on-chain finance" — a distinction the panel immediately roasts her for. Finally: prediction markets are in a legal bloodbath across state courts with a Supreme Court showdown likely by 2027, and the SEC's tokenized securities innovation exemption has Twitter buzzing but Rebecca skeptical. Let's get into it. Listen to the episode on Apple Podcasts, Spotify, Pods, Fountain, Podcast Addict, Pocket Casts, Amazon Music, or on your favorite podcast platform. Show highlights

Unpacking Hyperliquid's ATH with Michaël van de Poppe. In today's Markets Outlook, Michaël van de Poppe, Founder and CIO of MN Capital and MN Fund, joins CoinDesk's Jennifer Sanasie to share why Hyperliquid is hitting new all-time highs. He makes the case for NEAR and Bittensor as undervalued AI crypto plays compared to overhyped tech IPOs, and explains why he's steering clear of privacy coins like Zcash. Plus, his key macro signals to watch over the next four to six weeks. - Timecodes: 00:00 - What Michaël Is Watching in the Markets? 01:47 - Why European Traders Are Flocking to Hyperliquid 02:59 - HYPE Price Target & HYPE vs. Solana 05:09 - Responding to CME, ICE Regulatory Scrutiny of HYPE 07:27 - Are Altcoins Dead? 08:59 - The Case for NEAR Over AI IPOs 10:43 - Why Bittensor Could Reach $1,000-$2,000 12:48 - Privacy and Zcash 16:33 - Macro Outlook: Yields, the Fed, and What's Next - This episode was hosted by Jennifer Sanasie.

Unpacking Hyperliquid's ATH with Michaël van de Poppe. In today's Markets Outlook, Michaël van de Poppe, Founder and CIO of MN Capital and MN Fund, joins CoinDesk's Jennifer Sanasie to share why Hyperliquid is hitting new all-time highs. He makes the case for NEAR and Bittensor as undervalued AI crypto plays compared to overhyped tech IPOs, and explains why he's steering clear of privacy coins like Zcash. Plus, his key macro signals to watch over the next four to six weeks. - Timecodes: 00:00 - What Michaël Is Watching in the Markets? 01:47 - Why European Traders Are Flocking to Hyperliquid 02:59 - HYPE Price Target & HYPE vs. Solana 05:09 - Responding to CME, ICE Regulatory Scrutiny of HYPE 07:27 - Are Altcoins Dead? 08:59 - The Case for NEAR Over AI IPOs 10:43 - Why Bittensor Could Reach $1,000-$2,000 12:48 - Privacy and Zcash 16:33 - Macro Outlook: Yields, the Fed, and What's Next - This episode was hosted by Jennifer Sanasie.

Jennifer Katongole is a continuous improvement coach and facilitator based in Kampala, Uganda, working with Medical Teams International. With over 15 years in the nonprofit sector across Africa and the United States, Jennifer blends Lean and Kata thinking with facilitation to help teams break down silos, focus on what matters most, and deliver life-saving care in even the toughest environments.Through the teams she coaches, Medical Teams International has found practical ways to reach hard to access communities. From using donkeys to deliver nutrition supplies to remote villages, to redesigning blood donation systems in refugee camps, these improvements expand access, strengthen health systems, and save lives.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

We mark National Mental Health Awareness Month on this episode by tapping the expertise of Dr. Steve Strakowski, an internationally recognized expert in bipolar disorder, who has spent decades studying the neurobiology and treatment of mood conditions while pushing just as hard on the structural barriers that keep effective treatments out of reach for more than half the people who need them. In this conversation with Raise the Line from Elsevier host Michael Carrese, Dr. Strakowski explains why access, not science, is now the biggest obstacle to improving mental health outcomes. He also addresses the heavy toll society pays for underfunding mental health prevention and treatment programs. “The money is spent eventually, but in the most expensive places like emergency rooms and prisons, and there is the human cost of suffering and suicides." This important discussion also covers: The persistent problem of Black patients presenting with mania being misdiagnosed with schizophrenia;  Why he describes bipolar disorder as a reward-processing illness;  The emerging therapies he finds encouraging. Mentioned in this episode:Indiana University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Proceedings from a live event on April 12, 2026, held during the SGO 2026 Annual Meeting on Women's Cancer and moderated by Dr Shannon Westin, including the following topics: Introduction (0:00) Current Role of PARP Inhibitors for Advanced Ovarian Cancer — Prof Colombo (1:59) Strategies Targeting Folate Receptor Alpha for Advanced Ovarian Cancer — Dr Westin (25:53) Other Novel Agents and Strategies for Advanced Ovarian Cancer — Dr Olawaiye (46:40) Diagnosis and Management of Adverse Events Associated with Commonly Employed Therapies for Advanced Ovarian Cancer — Dr Konecny (1:19:11) CME information and select publications

Curious if your EMR frustrations could actually lead to a new career path? This episode might spark something unexpected. In this episode, I'm joined by Dr. Jonathan Komar, a physician who turned his curiosity about improving electronic medical records into a dynamic career in clinical informatics. What started as building templates and optimizing workflows in his own practice evolved into consulting, leadership, and system-wide impact across multiple clinics. Dr. Komar shares how physicians can explore informatics without leaving clinical work, the wide range of roles available, and why your frustrations with inefficient systems might actually be pointing you toward an exciting new direction. In this episode we're talking about: What clinical informatics is and the many directions it can take How to recognize early signs that informatics might be a good fit Simple ways to get involved, including becoming a "super user" How to build experience and credibility without formal certification Different career paths including consulting, training, and product development Opportunities to earn income through side gigs and part-time roles Why physician input is critical in shaping the future of healthcare technology Links for this episode: Dr. Jonathan Komar - LinkedIn Profile Episode #55: How About a Job Improving the EMR? Episode #65: Opportunities in Digital Health – Catch the Wave Episode #88: Find a New Career Direction by Solving a Problem Episode #129: Healthcare Informatics 101: Exciting Roles for Physicians in a Growing Field LinkedIn for Physicians Course - If you'd like to learn how to customize your LinkedIn profile to make it stand out to recruiters, this course walks you through all the steps with short, actionable videos and cheat sheets for each lesson. This course takes the guesswork out of using LinkedIn! Plus Earn up to 3 Category 1 CME credits ⭐ If you would like a sneak peek inside either the course before enrolling or have any questions, just email us at team@doctorscrossing.com. We're happy to give you a closer look. You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/episode247 Thank you for listening!

Featuring proceedings from a live event on January 9, 2026, held adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium and moderated by Dr Samuel J Klempner, including the following topics: Treatment approach for metastatic HER2-negative, claudin 18.2-positive, microsatellite instability-high gastroesophageal (GE) cancer (0:00) Duration of chemotherapy for patients with advanced GE cancers receiving nivolumab/chemotherapy (3:06) Younger patient with metastatic PD-L1-positive gastric cancer (5:29) CME information and select publications

CME and ICE want regulators to rein in Hyperliquid, which delivers 24/7 derivatives markets that incumbents can't match. Can it be brought onshore? ======================================================== Thank you to our sponsor! ⁠⁠⁠Coinbase One⁠⁠⁠: Get 20% off the first year of your Coinbase One annual plan at ⁠⁠⁠coinbase.com/unchained⁠⁠⁠. ======================================================== CME Group and Intercontinental Exchange have asked the CFTC to regulate Hyperliquid, the offshore perpetuals exchange that has rapidly become one of the largest derivatives venues in the world. The incumbents argue that price discovery is migrating to unregulated territory. Hyperliquid argues that its onchain transparency makes it less susceptible to manipulation, not more.  Walt Lukken, president and CEO of the Futures Industry Association, and Chris Perkins, CEO of 250 Digital Asset Management, sit down with Laura Shin to work through the options: come onshore and get the licenses, stay offshore and keep growing, or further decentralize until there is no entity left to regulate. The answer may reshape how global derivatives markets are built for the next decade. Host: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Laura Shin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, Host / Unchained Guests: Walt Lukken | President & CEO, Futures Industry Association Chris Perkins⁠ | CEO, 250 Digital Asset Management Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailIn this episode, we discuss one of the most important preparedness topics facing families today — food security in today's economy. With rising grocery prices, inflation, supply chain disruptions, economic uncertainty, and increasing concerns about the stability of the food system, more Americans are asking serious questions about how to protect and provide for their families long term.We explore practical ways individuals and families can improve food security through preparedness, home food storage, gardening, bulk purchasing, freeze-dried foods, food preservation, and developing self-reliance skills. This episode breaks down why food security is no longer just a concern for “preppers,” but something everyday families are beginning to think about as the cost of living continues to rise across the United States.We also discuss how economic conditions, fuel prices, transportation costs, and global instability affect the availability and affordability of food. Learn why many preparedness-minded families are building long-term food storage systems and taking steps now to become less dependent on fragile supply chains and centralized systems.This episode also touches on practical emergency preparedness topics, including:Long-term food storageFreeze-dried foodBulk food buyingGardening and homesteadingEmergency cooking methodsOff-grid preparednessInflation and rising food costsSupply chain disruptionsSelf-reliance and family preparednessBuilding a preparedness mindsetWe briefly discuss alternative cooking solutions like the Made in the USA, family-owned, veteran-owned My Solar Oven, which allows families to cook using the power of the sun without relying on electricity or fuel during emergencies or power outages.Whether you are just getting started in preparedness or already building a long-term plan for your family, this episode offers practical insights into why food security matters now more than ever. If you are concerned about inflation, economic instability, emergency preparedness, or becoming more self-reliant, this is an episode you will not want to miss. Join PrepperNet.Net - https://www.preppernet.netPrepperNet is an organization of like-minded individuals who believe in personal responsibility, individual freedoms and preparing for disasters of all origins.PrepperNet Support the showPlease give us 5 Stars! www.preppingacademy.com Daily deals for preppers, survivalists, off-gridders, homesteaders  https://prepperfinds.com www.preppernet.com

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Peter Lu talk to Dr. Maureen Leonard, a pediatric gastroenterologist and Associate Professor at Massachusetts General Hospital. Dr. Leonard discusses the latest research on early life factors that can increase celiac disease risk for susceptible children, including potentially modifiable risk factors. Dr. Leonard's disclosures include:  Consultant for Takeda, Chugai, Anokion, Sonoma, and Interlude Biopharma and research support from Takeda, Pfizer, Regeneron, Moderna, and Mead Johnson Nutrition.Learning objectivesUnderstand early life determinants for celiac diseaseUnderstand environmental influences on developing celiac diseaseSend us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

AI compute futures are now live on the CME, and IREN has raised $3B in a new convertible note offering. Welcome back to The Blockspace Podcast! Today for news, we cover IREN's new $3B convertible note – the largest convert ever for a public bitcoin miner – Trump's Q1 bitcoin equity buys, and the 90-day pause on zoning discussions for Hut 8's proposed 500 MW data center in Logan County, Illinois. Plus, Mike Alfred of Alpine Fox Hedge Fund joins us to discuss his top stock picks for AI, and Kush Bavaria of Ornn jumps on to discuss how Ornn is providing an H100 index for the CME's new AI compute futures – and his thoughts on the future of these incipient compute futures markets. Mike San Miguel of Luxor also joins us to discuss the latest in GPU markets and AI ASICs, and pseudonymous user Soup explains how he used Claude and $15 in tokens to spin up 3.5 trillion passwords to crack his long-lost bitcoin wallet.